Interní Med. 2005; 7(12): 534-538

Screening of sporadic colorectal cancer

doc. MUDr. Miroslav Zavoral Ph.D, MUDr. Ing. Filip Závada
Interní klinika 1. LF UK a Ústřední vojenské nemocnice, subkatedra gastroenterologie IPVZ, Praha

Secondary prevention of coleorectal cancer is focused on otherwise healthy idividuals. There are different laboratiory methods, imaging techniques and endocopic examinations used top screen the wide population. In most of the developed countries, including the Czech Republic, testing for faecal ocult blood is used as first line method. This examination should be routinely performed at the general practitioners office and is well accepted because of its noninvasiveness. Positive individuals undergo colonoscopy for establishment of diagnosis. Secondary prevention involves those, who are at increased risk of colorectal cancer. These patients are followed on a regular basis and as a part of the process, colonoscopy is included. Czech Republic ranks among the most developed countries, regarding the colorectal cancer screening scheme.

Keywords: Key words: colorectal cancer, secondary prevention, faecal occult blood test, colonoscopy, risk groups.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zavoral M, Závada F. Screening of sporadic colorectal cancer. Interní Med. 2005;7(12):534-538.
Download citation

References

  1. Birkner B, Altenhofen L, Brenner G, et al. Zwischenbilanz des Modellprojektes zur Foerderung der Frueherkennung des Kolorektalen Karzinoms. Forum, 13, 1998; 84-93.
  2. Frič P, Zavoral M, Dvořáková H, et al. An adapted program of colorectal cancer screening - 7-years experience and cost-benefits analysis. Hepato-Gastroenterology 1994; 41: 413-416. Go to PubMed...
  3. Frič P, Zoubek V, Dvořáková H, et al. Náklady a užitek depistáže kolorektálních nádorů Haemoccult(R) testem u asymptomatických jedinců ve věku 45-60 let. Čas Lék čes 1991; 130: 370-373.
  4. Frič P, Zavoral M, Čekal J, et al. Screening kolorektálního karcinomu v současném systému zdravotní péče (Pražský projekt). Endoskopie 1999; 8: 39-45.
  5. Gregor DH. Occult blood testing for detection of asymptomatic colorectal cancer. Cancer, 28, 1971; 131-134. Go to original source... Go to PubMed...
  6. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised control trial of fecal occult blood screening for colorectal cancer. Lancet, 348, 1996; 1472-1477. Go to original source... Go to PubMed...
  7. Chaoui AS, Blake MA, Barish MA, et al. Virtual colonoscopy and colorectal cancer screening. Abdom Imaging, 25, 2000; 361-367. Go to original source... Go to PubMed...
  8. Jablonská M, Řezníková, Kotrlík J. Clinical implications of recognitions of the hereditary nonpolyposis cancer syndrome (HNPCC) for the early detection of colorectal cancer. Sbor Lék, 96,1995; 275-282.
  9. Kronborg O, Fenger C, Olson J, et al. Randomised study of screening for colorectal cancer with fecal ocult blood test. Lancet, 348, 1996; 1467-1471. Go to original source... Go to PubMed...
  10. Liebermann DA. Cost-effectiveness model for colon cancer screening. Gastroenterology, 109, 1995; 1781-1790. Go to original source... Go to PubMed...
  11. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med, 328, 1993; 1365-1371. Go to original source... Go to PubMed...
  12. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal Cancer Screening. Clinical Guidelines and Rationale. Gastroenetrology, 112, 1997; 584-642. Go to original source... Go to PubMed...
  13. Zavoral M, Ladmanová P, Horák L, Ambruš M: Kolorektální karcinom - screening, diagnostika, léčba. Dostupné na webových stránkách ČGS: http://www1.lf1.cuni.cz/~kocna/gastro/main.htm




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.